GORE VIABAHN Endoprosthesis Versus Percutaneous Transluminal Angioplasty (PTA) to Revise AV Grafts in Hemodialysis
Public ClinicalTrials.gov record NCT00737672. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
GORE VIABAHN® Endoprosthesis Versus Percutaneous Transluminal Angioplasty (PTA) to Revise Arteriovenous Grafts at the Venous Anastomosis in Hemodialysis Patients
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of the study is to establish efficacy and safety of the GORE VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface when used to revise arteriovenous (AV) prosthetic grafts at the venous anastomosis in the maintenance or re-establishment of vascular access for hemodialysis.
Study identification
- NCT ID
- NCT00737672
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 293 participants
Conditions and interventions
Conditions
Interventions
- GORE VIABAHN Endoprosthesis with PROPATEN Bioactive Surface Device
- Percutaneous Transluminal Angioplasty Procedure
Device · Procedure
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2008 (Type not available)
- Primary completion
- May 2011 (Actual)
- Completion
- Jun 2013 (Actual)
- Last update posted
- Oct 21, 2014
2008 – 2013
United States locations
- U.S. sites
- 31
- U.S. states
- 18
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | 35249 | — |
| Not listed | Fresno | California | 93710 | — |
| Not listed | Inglewood | California | 90301 | — |
| Not listed | Oceanside | California | 92056 | — |
| Not listed | Riverside | California | 92501 | — |
| Not listed | San Diego | California | 92115 | — |
| Not listed | San Diego | California | 92120 | — |
| Not listed | San Francisco | California | 94143 | — |
| Not listed | New Haven | Connecticut | 06520 | — |
| Not listed | Jacksonville | Florida | 32209 | — |
| Not listed | Albany | Georgia | 31707-1908 | — |
| Not listed | Chicago | Illinois | 60612-3833 | — |
| Not listed | Des Moines | Iowa | 50309 | — |
| Not listed | Louisville | Kentucky | 40202 | — |
| Not listed | Baltimore | Maryland | 21239 | — |
| Not listed | New Brighton | Minnesota | 55112 | — |
| Not listed | Saint Paul | Minnesota | 55101 | — |
| Not listed | Cincinnati | Ohio | 45212 | — |
| Not listed | Cincinnati | Ohio | 45267-0585 | — |
| Not listed | Dayton | Ohio | 45406 | — |
| Not listed | Portland | Oregon | 97210 | — |
| Not listed | Philadelphia | Pennsylvania | 19104 | — |
| Not listed | Charleston | South Carolina | 29421 | — |
| Not listed | Greenville | South Carolina | 29615 | — |
| Not listed | Beaumont | Texas | 77701 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | Norfolk | Virginia | 23507 | — |
| Not listed | Winchester | Virginia | 22601 | — |
| Not listed | Bellevue | Washington | 98004 | — |
| Not listed | Spokane | Washington | 99204 | — |
| Not listed | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00737672, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 21, 2014 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00737672 live on ClinicalTrials.gov.